Clinical trial Recruiting at 1 site Interventional Ages 4 to 12

Visual and perceptual training to improve sight after congenital ectopia lentis surgery in children

Official title: Efficacy of Visual and Perceptual Training on Visual Function for Operative Congenital Ectopia Lentis Children: A Randomized Controlled Clinical Trial

Run by Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07096622 · Data updated 2026-11-12

We will try a web-based visual and perceptual training program to see if it improves vision, stereoacuity, quality of life, and treatment adherence in children after surgery for congenital ectopia lentis.

More Ectopia Lentis trials

Quick facts

Study typeInterventional
Ages4 Years to 12 Years
SexAll
Enrollment82 (estimated)
SponsorZhongshan Ophthalmic Center, Sun Yat-sen University
Academic / other
Locations2 sites (Guangzhou, Guangdong and 1 other locations)
StatusRecruiting
StartedJune 1, 2026
Main results expectedJune 30, 2029
Study endsJune 30, 2029
Registry record updatedApril 27, 2026
Trial IDNCT07096622 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 4–12 years with congenital ectopia lentis who have had bilateral lensectomy with IOL scleral fixation and are around one month after their second-eye surgery, with best-corrected visual acuity between ≤20/200 and below the normal level for their age, are ideal candidates.

Probably not a fit

Children with a history of ocular trauma or previous non-study ocular surgery, severe coexisting eye conditions (e.g., recurrent lens dislocation, dense central cataract, secondary glaucoma, corneal endothelial decompensation, retinal detachment), or those unable to cooperate with treatment and follow-up are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter, open-label, parallel-group randomized trial comparing web-based visual perceptual training (HVT) with routine postoperative rehabilitation in children who have undergone bilateral lensectomy with IOL scleral fixation for congenital ectopia lentis. Eligible participants are 4–12 years old and enrolled about one month after their second-eye surgery, with best-corrected visual acuity no worse than 20/200 but below age-normal levels. Primary outcomes include changes in visual function, with secondary outcomes of stereoacuity, quality of life scores, treatment compliance, and safety of the software-based intervention. The study is being conducted at Zhongshan Ophthalmic Center and affiliated hospitals in Guangdong, China to produce evidence-based recommendations for visual rehabilitation in this population.

Why it matters

Potential benefit: If successful, the program could improve visual acuity, binocular vision, and quality of life for postoperative congenital ectopia lentis children while offering a scalable, home-delivered rehabilitation option.

How similar studies have gone: Digital visual perceptual training has shown promising, faster improvements in visual acuity and binocular function in amblyopia and related conditions, but its specific use after congenital ectopia lentis surgery is novel and less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

1. Aged 4-12 years, with no gender restriction;
2. Diagnosed with congenital ectopia lentis;
3. Underwent bilateral lensectomy combined with IOL scleral fixation, and within 1 month ± 1 week after the second-eye surgery;
4. Best-corrected visual acuity (BCVA) of unilateral or bilateral eyes is no worse than 20/200 but below the normal level for the corresponding age: for 4-year-old children, BCVA ≤ 20/40; for children aged 5 years and above, BCVA ≤ 20/30;
5. Written informed consent signed by the patient and their parents or legal guardians.

Exclusion Criteria

1. History of ocular trauma or previous ocular surgery other than the study-related procedure;
2. Unable to cooperate with treatment, examinations, and follow-up assessments;
3. Complicated with recurrent lens dislocation, severe cataract (dense, axial, opacity diameter \>3 mm and affecting central vision), secondary glaucoma, corneal endothelial decompensation, retinal detachment, or other conditions requiring urgent surgical intervention;
4. Presence of diplopia in either eye;
5. Known history of neurological disorders (e.g., photosensitive epilepsy);
6. Participation in other clinical trials within the postoperative period that may affect the outcomes of the present study;
7. Use of topical or systemic medications that may cause visual impairment, or other vision therapies other than refractive correction in the past 3 months (e.g., atropine penalization, occlusion therapy, digital therapy, Bangerter filters, optical suppression, VR training, etc.).

Where it's running

  • Guangdong Provincial Clinical Research Center for Ocular Diseases, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, Guangdong
    Guangzhou, Guangdong, China
    Recruiting
  • Qingyuan Hospital Affiliated to Guangzhou Medical University (Qingyuan People's Hospital)
    Qingyuan, Guangdong, China
    Not yet recruiting

Study contacts

  • Principal investigator: Guangming Jin, M.D. — Guangdong Provincial Clinical Research Center for Ocular Diseases, State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, Guangdong
  • Study coordinator: Guangming Jin, Ph.D.
  • Email: jinguangming@gzzoc.com
  • Phone: +86 02066604125

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.